Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |